News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti
505(b)(2) NDA on track for FDA submission in Q1 2018.
October 23, 2017
·
6 min read
Kyomed Nominated For A 2017 Galien MedStartUp Award
Kyomed announces its selection, in conjunction with project leader Neogia and project partner Bluesleep clinic, as a finalist in the 2017 MedStartup awards.
October 23, 2017
·
3 min read
Drug Development
Reata Announces First Patient Enrolled in Part II of MOXIe Study of Omaveloxolone for the Treatment of Friedreich’s Ataxia
The trial will enroll approximately 100 FA patients randomized evenly to either 150 mg of omaveloxolone or placebo.
October 23, 2017
·
4 min read
Business
Rapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for Vaccines
This awarded grant is part of BARDA’s Advance Development of Medical Countermeasures for Pandemic Influenza, which focuses on improving the government’s responsiveness to future pandemic threats.
October 23, 2017
·
2 min read
Policy
MannKind and BIOMM Submit Registration Dossier to Brazilian Health Regulatory Agency (ANVISA)
Afrezza is the only inhaled rapid-acting mealtime insulin approved by the U.S. Food & Drug Administration.
October 23, 2017
·
4 min read
Business
Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment
Queen’s University Belfast have led the world’s largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours.
October 23, 2017
·
4 min read
Cesar Millan helps Avivagen Relaunch Vivamune Health Chews in U.S.
At the heart of Vivamune is an active substance, called OxC-beta (OxC-beta) compound, Avivagen’s proprietary formulation of fully oxidized β-carotene.
October 23, 2017
·
6 min read
Business
Recipharm Equips Lisbon Facility for US and European Serialisation
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.
October 23, 2017
·
3 min read
Biotech Bay
Soleno Therapeutics Regains Compliance With NASDAQ Listing Requirements
Soleno is in compliance with all applicable listing standards and its common stock will continue to be listed on The NASDAQ Capital Market and NASDAQ considers the matter closed.
October 23, 2017
·
2 min read
Business
Pixium Vision Establishes an Equity Line Financing With Kepler Cheuvreux
Pixium Vision announces the implementation of an equity line financing facility with Kepler Cheuvreux.
October 23, 2017
·
4 min read
Previous
4 of 16
Next